Form 4: Arvinas Director Laurie Smaldone Alsup Granted Significant Equity Awards

Arvinas, Inc. Director Laurie Smaldone Alsup was granted 16,025 restricted stock units and 23,105 stock options, aligning her interests with shareholders.

Summary

• Laurie Smaldone Alsup, a Director of Arvinas, Inc. (ARVN), was granted equity awards on June 25, 2025.
• She received 16,025 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of common stock for no consideration.
• These RSUs will vest in full on the earlier of June 25, 2026, or the first meeting of the board of directors held after the next annual meeting of stockholders, subject to her continued service.
• Additionally, she was granted stock options to purchase 23,105 shares of common stock at an exercise price of $7.8 per share.
• These stock options also vest in full on the earlier of June 25, 2026, or the first meeting of the board of directors held after the next annual meeting of stockholders, subject to her continued service.
• The stock options have an expiration date of June 24, 2035.
• Following these transactions, Ms. Smaldone Alsup beneficially owns 26,045 shares of common stock directly and 23,105 derivative securities (stock options) directly.
• The filing was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged transaction.

Sentiment

Score: 7

Explanation: The sentiment is positive as it indicates alignment of a director's interests with shareholders through equity grants. However, it is a routine compensation disclosure and not a major strategic or financial announcement.

Positives

• The granting of restricted stock units and stock options to a director aligns management's interests with those of shareholders, incentivizing long-term company performance.
• The awards are part of a Rule 10b5-1(c) plan, indicating a pre-scheduled and transparent transaction.

Future Outlook

The document primarily reports past and scheduled equity grants and does not provide forward-looking statements or guidance on company performance or financial outlook.

Industry Context

This filing is a routine disclosure of insider equity compensation, common across all industries, particularly in biotechnology companies like Arvinas, where equity incentives are a standard component of director and executive compensation to align interests with long-term value creation.

Corporate Governance

Stakeholder Impact

• Shareholders: The equity grants align the director's financial interests with shareholder value creation, potentially leading to more focused long-term decision-making.
• Employees: While not directly impacting all employees, director compensation practices can reflect the company's overall approach to incentivizing its leadership.

Next Steps

• The Restricted Stock Units and Stock Options are scheduled to vest on the earlier of June 25, 2026, or the first board meeting after the next annual meeting of stockholders, contingent on continued service.

Key Dates

Keywords

Arvinas, ARVN, SEC Form 4, Insider Transaction, Equity Grant, Restricted Stock Units, RSU, Stock Options, Director Compensation, Corporate Governance, Rule 10b5-1